QIM
HZNP

Quantitative Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Quantitative Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8,773
Closed -$960K – 498
2021
Q3 		$960K Buy
8,773
+3,676
+72% +$382K 0.09% 206
2021
Q2 		$477K Sell
5,097
-14,624
-74% -$1.35M 0.04% 292
2021
Q1 		$1.81M Buy
+19,721
New +$1.66M 0.15% 166
2020
Q3 		– Sell
-12,036
Closed -$668K – 655
2020
Q2 		$668K Buy
+12,036
New +$515K 0.07% 284
2020
Q1 		– Sell
-122,605
Closed -$4.44M – 901
2019
Q4 		$4.44M Sell
122,605
-41,647
-25% -$1.28M 0.13% 176
2019
Q3 		$4.47M Buy
+164,252
New +$4.25M 0.24% 117
2019
Q2 		– Sell
-116,025
Closed -$3.07M – 898
2019
Q1 		$3.07M Buy
116,025
+94,225
+432% +$2.23M 0.18% 167
2018
Q4 		$425K Sell
21,800
-19,800
-48% -$388K 0.02% 401
2018
Q3 		$814K Sell
41,600
-108,700
-72% -$2.07M 0.03% 344
2018
Q2 		$2.49M Buy
+150,300
New +$2.29M 0.05% 328
2016
Q3 		– Sell
-30,500
Closed -$502K – 951
2016
Q2 		$502K Sell
30,500
-6,300
-17% -$102K 0.02% 546
2016
Q1 		$609K Buy
+36,800
New +$644K 0.03% 511
2015
Q4 		– Sell
-126,100
Closed -$2.5M – 921
2015
Q3 		$2.5M Buy
+126,100
New +$3.98M 0.19% 138
2015
Q2 		– Sell
-52,800
Closed -$1.37M – 765
2015
Q1 		$1.37M Buy
+52,800
New +$968K 0.13% 144
2014
Q4 		– Sell
-20,500
Closed -$251K – 623
2014
Q3 		$251K Buy
+20,500
New +$238K 0.05% 274

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Quantitative Investment Management's HZNP Position: Q4 2021 in Review

Quantitative Investment Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2021, closing a stake of 8,773 shares — an estimated $960K sold.

Quantitative Investment Management first reported a position in HZNP in Q3 2014 and held it in 15 quarters. The position peaked at $4.47M in Q3 2019. 610 funds tracked by Wall St. Rank hold HZNP as of Q4 2021.

  • Quantitative Investment Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2021 after selling out during the quarter.
  • Quantitative Investment Management sold 8,773 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2021, an estimated $960K.
  • Quantitative Investment Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2014 and held it in 15 quarters.
  • Quantitative Investment Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $4.47M in Q3 2019.
  • 610 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2021.

Based on Quantitative Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.